Patents by Inventor Eizirik Decio LAKS

Eizirik Decio LAKS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells
    Patent number: 11243214
    Abstract: The present invention is directed to the identification of a biomarker specifically located in the plasma membrane of pancreatic beta cells. Based on a set of specific features the biomarker is a unique candidate for imaging and targeting strategies to study the pancreatic beta cell mass in health and disease (T1D, T2D, pancreatic cancers, obesity, islet transplantation, beta cell regeneration).
    Type: Grant
    Filed: April 21, 2017
    Date of Patent: February 8, 2022
    Assignees: UNIVERSITÉ LIBRE DE BRUXELLES, VRIJE UNIVERSITES BRUSSEL
    Inventors: Eizirik Decio Laks, Alexander Balhuizen, Nick Mark Devoogdt, Sam Marc Kris Aimé Massa, Luc Bouwens, Iris Mathijs
  • A NEW BIOMARKER EXPRESSED IN PANCREATIC BETA CELLS USEFUL IN IMAGING OR TARGETING BETA CELLS
    Publication number: 20190145987
    Abstract: The present invention is directed to the identification of a biomarker specifically located in the plasma membrane of pancreatic beta cells. Based on a set of specific features the biomarker is a unique candidate for imaging and targeting strategies to study the pancreatic beta cell mass in health and disease (T1D, T2D, pancreatic cancers, obesity, islet transplantation, beta cell regeneration).
    Type: Application
    Filed: April 21, 2017
    Publication date: May 16, 2019
    Inventors: Eizirik Decio LAKS, Alexander BALHUIZEN, Nick Mark DEVOOGDT, Sam Marc Kris Aimé MASSA, Luc BOUWENS, Iris MATHIJS